41 studies found for:    " August 25, 2009":" September 24, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Trial Embedded in an Electronic Personal Medical Health Records
Conditions: HIV Infections;   Health Literacy
Interventions: Other: Online access to a personal health record;   Other: No access to the PHR
22 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa
Condition: HIV Infections
Interventions: Drug: FTC/TDF;   Drug: Placebo
23 Completed Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: mefloquine
24 Completed
Has Results
Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
Condition: HIV Infection
Interventions: Biological: DNA + HIV-rAd5 vaccine;   Drug: ART intensification (raltegravir);   Drug: ART intensification (maraviroc)
25 Completed Infant Male Circumcision in Gaborone, Botswana, and Surrounding Areas: Feasibility, Safety and Acceptability
Conditions: HIV Infections;   Circumcision
Interventions: Procedure: Circumcision;   Device: Mogen Clamp;   Device: Plastibell;   Device: AccuCirc
26 Completed Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients
Conditions: HIV Infections;   Lipoatrophy
Interventions: Drug: EFV;   Drug: LPV/r
27 Completed Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis
Conditions: Cryptococcal Meningitis;   HIV Infections
Intervention: Other: Early antiretroviral therapy
28 Completed Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects
Conditions: HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: control group
29 Completed Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose
Conditions: Immunologic Tests;   HIV Infections
Interventions: Biological: GSK Biologicals' HIV vaccine (732461);   Drug: Chloroquine
30 Completed
Has Results
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Conditions: Hepatitis C;   HIV Infections
Interventions: Drug: telaprevir or matching placebo;   Biological: peginterferon alfa-2a;   Drug: ribavirin (fixed dose);   Drug: ribavirin (weight-based dose)
31 Completed The Maraviroc Central Nervous System (CNS) Study
Condition: HIV Infections
Intervention: Drug: Maraviroc
32 Completed
Has Results
The Raltegravir and Ribavirin Pharmacokinetics (PK) Study
Condition: HIV Infections
Interventions: Drug: Ribavirin;   Drug: Raltegravir
33 Completed
Has Results
Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune
Condition: HIV Infections
Intervention:
34 Completed IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
Condition: HIV Infections
Interventions: Drug: Raltegravir (RAL);   Drug: Atazanavir (ATV);   Drug: Ritonavir (RTV);   Drug: Tenofovir (TDF);   Drug: Etravirine (ETV);   Drug: Darunavir (DRV);   Drug: Maraviroc (MVC);   Drug: Lopinavir/ritonavir (LPV/r)
35 Completed
Has Results
A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: ritonavir
36 Completed Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.
Condition: HIV Infections
Intervention: Drug: bevirimat dimeglumine
37 Completed Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
Conditions: Lymphoma;   Nonneoplastic Condition
Interventions: Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis
38 Completed Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
Condition: Influenza
Interventions: Drug: Oseltamivir Phosphate;   Drug: ADS-8902
39 Completed Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects
Conditions: Thalassemia;   Sickle Cell Anemia
Intervention: Other: Clinical medical record summary
40 Unknown  Manicaland Cash Transfer Trial
Conditions: Vaccination;   Education;   Birth Registration;   Financial Support
Interventions: Other: Conditional Cash Transfer;   Other: Unconditional Cash Transfers;   Other: Standard Agricultural Package;   Other: Parenting Skills Classes

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years